1. Home
  2. FLYX.WS vs LTRN Comparison

FLYX.WS vs LTRN Comparison

Compare FLYX.WS & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FLYX.WS

flyExclusive Inc. Redeemable warrants each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 per share

N/A

Current Price

$0.14

Market Cap

9.6M

ML Signal

N/A

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$0.39

Market Cap

10.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLYX.WS
LTRN
Founded
N/A
2013
Country
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6M
10.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FLYX.WS
LTRN
Price
$0.14
$0.39
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $17.50
AVG Volume (30 Days)
N/A
★ 218.7K
Earning Date
N/A
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.65
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$0.42
52 Week High
N/A
$4.34

Technical Indicators

Market Signals
Indicator
FLYX.WS
LTRN
Relative Strength Index (RSI) N/A 25.41
Support Level N/A N/A
Resistance Level N/A $0.84
Average True Range (ATR) 0.00 0.10
MACD 0.00 0.01
Stochastic Oscillator 0.00 4.39

Price Performance

Historical Comparison
FLYX.WS
LTRN

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: